Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis.
Adverse drug events (ADE) cause considerable harm to patients, and consequently their detection is critical for patient safety. The US Food and Drug Administration maintains an adverse event reporting system (AERS) to facilitate the detection of ADE in drugs. Various data mining approaches have been developed that use AERS to detect signals identifying associations between drugs and ADE. The signals must then be monitored further by domain experts, which is [...]
Author(s): Vilar, Santiago, Harpaz, Rave, Chase, Herbert S, Costanzi, Stefano, Rabadan, Raul, Friedman, Carol
DOI: 10.1136/amiajnl-2011-000417